U.S. markets close in 19 minutes
  • S&P 500

    3,842.73
    +0.79 (+0.02%)
     
  • Dow 30

    31,973.22
    +476.92 (+1.51%)
     
  • Nasdaq

    12,678.20
    -241.95 (-1.87%)
     
  • Russell 2000

    2,202.18
    +9.97 (+0.45%)
     
  • Crude Oil

    64.77
    -1.32 (-2.00%)
     
  • Gold

    1,678.70
    -19.80 (-1.17%)
     
  • Silver

    25.22
    -0.07 (-0.26%)
     
  • EUR/USD

    1.1854
    -0.0071 (-0.59%)
     
  • 10-Yr Bond

    1.5960
    +0.0420 (+2.70%)
     
  • GBP/USD

    1.3825
    -0.0003 (-0.02%)
     
  • USD/JPY

    108.9050
    +0.5230 (+0.48%)
     
  • BTC-USD

    51,505.57
    +996.58 (+1.97%)
     
  • CMC Crypto 200

    1,042.18
    +17.98 (+1.76%)
     
  • FTSE 100

    6,719.13
    +88.61 (+1.34%)
     
  • Nikkei 225

    28,743.25
    -121.07 (-0.42%)
     

ChromaDex (CDXC) in Focus: Stock Moves 5.6% Higher

  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

ChromaDex Corporation CDXC was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $4.80 to $5.07 in the past one-month time frame.

The company has seen two positive estimate revisions in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few months, suggesting that more solid trading could be ahead for ChromaDex. So, make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

ChromaDex currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

ChromaDex Corporation Price

ChromaDex Corporation Price
ChromaDex Corporation Price

ChromaDex Corporation price | ChromaDex Corporation Quote

A better-ranked stock in the Medical - Biomedical and Genetics industry is Pharma Mar, S.A. PHMMF, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The Hottest Tech Mega-Trend of All

Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
ChromaDex Corporation (CDXC) : Free Stock Analysis Report
 
PHARMA MAR SA (PHMMF) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research